Latest Insights on PPA
Pfizer’s Pforce Awakens, Apple Strikes Back & CVS’s New Hope
May 4, 2021 Great Stuff
May The Pfourth Be With You Great Ones, I don’t know if we officially have a winner in the COVID-19 vaccine race, but we certainly have a new front-runner: Pfizer (NYSE: ). I know. I didn’t see it coming either. Apparently, Pfizer makes more than just Viagra. Who knew? OK, I knew. But I didn’t […] Old Man Yells At Bitcoin, Verizon’s Yard Sale & Tesla Battles The Bulge
May 3, 2021 Great Stuff
Berkshire’s Munger Strike Berkshire Hathaway (NYSE: ) had a shareholders meeting this weekend. And we should care because? Agreed. No one cares about Berkshire events. I mean, the stock trades north of $420,000 per share. Do you own BRK.A? If so, why are you reading me? Am I that entertaining? (I hope so.) Anyway, Berkshire […] Apple’s Antitrust Agony, Amazon Amazes All & Nio’s Nagging Negativity
April 30, 2021 Great Stuff
Friday Four Play: The “Apple A Day” Edition Apple (Nasdaq: ) core! Baltimore. Who’s your friend? Not the EU, that’s for certain. European regulators hit Apple with its first antitrust suit in the EU. The charge stems from a 2019 complaint by Spotify (NYSE: ) that Apple abused its position in music streaming via restrictive […] Finding Fibonacci, Rallying Roku, Gaging Google & Martian Musk
April 29, 2021 Great Stuff
Technically Correct Is the Best Correct Hey! Hey, Great Ones! What day is it? That’s right: It’s Reader Feedback day, awww yeah! Today, we answer your questions on technical trading analysis — Oh, look at the big brain on Brad! — Google (Nasdaq: ), Roku (Nasdaq: ), Tesla (Nasdaq: ) and its egocentric CEO Elon […] Quantum Con Short-a-Thon, AMC You Later & Enough Esports?
April 16, 2021 Great Stuff
Friday Four Play: The “Two Wrongs Don’t Make A Right” Edition Great Ones, today I’m tempted to change my opinion on a stock out of simple spite alone. That stock is solid-state battery researcher QuantumScape (NYSE: ). Regular Great Ones know that QuantumScape is my go-to punching bag for everything that’s wrong with the SPAC […]